The article discusses within a health technology assessment context, the policy changes within the UK NHS Pathology Service in respect to manufacturing pricing and reimbursement for Point of Care Technologies (POCT) used for Cardiac Marker testing and how these strategies may be able to overcome adoption and implementation barriers.
|Publisher||Canon Communications LLC|
|Publication status||Published - 22 Jun 2011|
- Market Access
- Point of Care
- Cardiac Markers